What is Insmed's net change in cash and restricted cash?

Insmed (INSM) reported net change in cash and restricted cash of $71.74M in Q1 2026.

How has Insmed's net change in cash and restricted cash changed year-over-year?

Insmed's net change in cash and restricted cash increased by 147.3% year-over-year, from -$151.78M to $71.74M.

What is the long-term trend for Insmed's net change in cash and restricted cash?

Over 2 years (2022 to 2024), Insmed's net change in cash and restricted cash has grown at a -54.9% compound annual growth rate (CAGR), from $357.25M to $72.66M.

What does net change in cash and restricted cash mean?

The total net movement in the company's available cash and restricted cash reserves during the period.

Discontinued — last reported Q4 '25

Other

Net Change in Cash and Restricted Cash

Insmed Net Change in Cash and Restricted Cash increased by 107.6% to $71.74M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 147.3%, from -$151.78M to $71.74M. Over 2 years (FY 2022 to FY 2024), Net Change in Cash and Restricted Cash shows a downward trend with a -54.9% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementIncome Statement

SectionOther

CategoryLiquidity

SignalHigher is better

VolatilityModerate

First reportedQ1 2013

Last reportedQ4 2025

How to read this metric

A positive change indicates net cash generation, while a negative change indicates net cash consumption.

Detailed definition

This represents the total net increase or decrease in the company's cash, cash equivalents, and restricted cash balances...

Peer comparison

A standard liquidity metric found in the statement of cash flows for all public companies.

Metric ID: cvx_net_change_in_cash_and_restricted_cash

Historical Data

18 periods

	Q2 '21	Q3 '21	Q1 '22	Q2 '22	Q3 '22	Q4 '22	Q1 '23	Q2 '23	Q3 '23	Q4 '23	Q1 '24	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q1 '26
Value	$518.58M	-$81.77M	-$201.08M	-$99.63M	-$1.45M	$659.40M	-$105.13M	-$356.03M	-$125.77M	-$4.74M	$113.36M	$651.07M	-$785.35M	$93.58M	-$151.78M	$881.08M	-$949.56M	$71.74M
QoQ Change	—	-115.8%	-145.9%	+50.5%	+98.5%	>999%	-115.9%	-238.7%	+64.7%	+96.2%	>999%	+474.4%	-220.6%	+111.9%	-262.2%	+680.5%	-207.8%	+107.6%
YoY Change	—	—	—	-119.2%	+98.2%	—	+47.7%	-257.4%	<-999%	-100.7%	+207.8%	+282.9%	-524.4%	>999%	-233.9%	+35.3%	-20.9%	+147.3%

Range-$949.56M – $881.08M

CAGR-37.2%

Avg YoY Growth-497.6%

Median YoY Growth+7.2%

Frequently Asked Questions

What is Insmed's net change in cash and restricted cash?: Insmed (INSM) reported net change in cash and restricted cash of $71.74M in Q1 2026.
How has Insmed's net change in cash and restricted cash changed year-over-year?: Insmed's net change in cash and restricted cash increased by 147.3% year-over-year, from -$151.78M to $71.74M.
What is the long-term trend for Insmed's net change in cash and restricted cash?: Over 2 years (2022 to 2024), Insmed's net change in cash and restricted cash has grown at a -54.9% compound annual growth rate (CAGR), from $357.25M to $72.66M.
What does net change in cash and restricted cash mean?: The total net movement in the company's available cash and restricted cash reserves during the period.